合成路线1
该中间体在本合成路线中的序号:
(V) The condensation of ethyl 4-chloroacetoacetate (I) with 2-azidoethanol (II) by means of NaH in THF gives ethyl 4-(2-azidoethoxy)acetoacetate (III), which is submitted to a Hantzsch cyclocondensation with methyl 3-aminocrotonate (IV) and 2-chlorobenzaldehyde (V) in refluxing methanol affording 3-ethyl 5-methyl 2-(2-azidoethoxymethyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methylpyridine-3,5-dicarboxylate (VI), Finally, this compound is reduced with Zn and 3N HCl in methanol, or with H2 over Pd/CaCO3 in ethanol.
【1】
Campbell, S.F.; Cross, P.E.; Stubbs, J.K. (Pfizer Inc.); 2-(Secondary aminoalkoxymethyl)dihydropyridine derivatives as anti-ischaemic and antihypertensive agents. DD 218887; EP 0089167; JP 58167569; US 4572909 .
|
【2】
Castaner, J.; Prous, J.; Amlodipine. Drugs Fut 1986, 11, 2, 89.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
23541 |
ethyl 4-chloro-3-oxobutanoate;Ethyl 4-chloro-3-oxobutanoate;Ethyl 4-chloroacetoacetate |
638-07-3 |
C6H9ClO3 |
详情 | 详情
|
(II) |
24111 |
2-azido-1-ethanol
|
|
C2H5N3O |
详情 |
详情
|
(III) |
24112 |
ethyl 4-(2-azidoethoxy)-3-oxobutanoate
|
|
C8H13N3O4 |
详情 |
详情
|
(IV) |
11372 |
Methyl (E)-3-amino-2-butenoate; Methyl 3-aminocrotonate
|
|
C5H9NO2 |
详情 |
详情
|
(V) |
24114 |
2-chlorobenzaldehyde
|
89-98-5 |
C7H5ClO |
详情 | 详情
|
(VI) |
24115 |
3-ethyl 5-methyl 2-[(2-azidoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydro-3,5-pyridinedicarboxylate
|
|
C20H23ClN4O5 |
详情 |
详情
|
合成路线2
该中间体在本合成路线中的序号:
(V) The reduction of 2,2-diethoxyacetic acid ethyl ester (I) with NaBH4 in dimethoxyethane gives 2,2-diethoxyethanol (II), which is condensed with ethyl 4-chloroacetoacetate (III) by means of NaH in hot THF to yield ethyl 4-(2,2-diethoxyethoxy)acetoacetate (IV). The condensation of (IV) with 2-chlorobenzaldehyde (V) by means of piperidine in refluxing toluene affords the acrylic ester (VI), which is cyclized with methyl 3-aminocrotonate (VII) in refluxing toluene to provide the dihydropyridine (VIII). The reaction of (VIII) with hydroxylamine in refluxing methanol/water gives the hydroxyimino derivative (IX), which is finally reduced to the target compound by means of H2 over Pd/C in acetic acid or with NaBH4 and NiCl2 in methanol.
Alternatively, intermediate dihydropyridine (VIII) can be obtained as follows: The reaction of acetoacetate (IV) with ammonium acetate in refluxing ethanol gives ethyl 3-amino-4-(2,2-diethoxyethoxy)crotonate (X), which is cyclized with methyl 2-(2-chlorobenzylidene)acetoacetate (XI) in refluxing toluene to yield the target intermediate the dihydropyridine (VIII).
【1】
Pedersen, S.B.; Preikschat, H.F.; Karup, G.L. (GEA A/S Farmaceutisk Fabrik); Process for the preparation of acetal derivs. of 1,4-dihydropyridines. WO 9925689 .
|
【2】
Karup, G.L.; Preikschat, H.F. (GEA A/S Farmaceutisk Fabrik); Process for the preparation of 1,4-dihydropyridines and cpds. used in this process. WO 9925688 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
25674 |
ethyl 2,2-diethoxyacetate
|
6065-82-3 |
C8H16O4 |
详情 | 详情
|
(II) |
48253 |
2,2-diethoxy-1-ethanol
|
621-63-6 |
C6H14O3 |
详情 | 详情
|
(III) |
23541 |
ethyl 4-chloro-3-oxobutanoate;Ethyl 4-chloro-3-oxobutanoate;Ethyl 4-chloroacetoacetate |
638-07-3 |
C6H9ClO3 |
详情 | 详情
|
(IV) |
48254 |
ethyl 4-(2,2-diethoxyethoxy)-3-oxobutanoate
|
|
C12H22O6 |
详情 |
详情
|
(V) |
24114 |
2-chlorobenzaldehyde
|
89-98-5 |
C7H5ClO |
详情 | 详情
|
(VI) |
48255 |
ethyl (Z)-3-(2-chlorophenyl)-2-[2-(2,2-dimethoxyethoxy)acetyl]-2-propenoate
|
|
C17H21ClO6 |
详情 |
详情
|
(VII) |
11372 |
Methyl (E)-3-amino-2-butenoate; Methyl 3-aminocrotonate
|
|
C5H9NO2 |
详情 |
详情
|
(VIII) |
48256 |
3-ethyl 5-methyl 4-(2-chlorophenyl)-2-[(2,2-dimethoxyethoxy)methyl]-6-methyl-1,4-dihydro-3,5-pyridinedicarboxylate
|
|
C22H28ClNO7 |
详情 |
详情
|
(IX) |
48258 |
3-ethyl 5-methyl 4-(2-chlorophenyl)-2-[[2-(hydroxyimino)ethoxy]methyl]-6-methyl-1,4-dihydro-3,5-pyridinedicarboxylate
|
|
C20H23ClN2O6 |
详情 |
详情
|
(X) |
48257 |
ethyl (E)-3-amino-4-(2,2-diethoxyethoxy)-2-butenoate
|
|
C12H23NO5 |
详情 |
详情
|
(XI) |
44034 |
methyl (Z)-2-acetyl-3-(2-chlorophenyl)-2-propenoate
|
|
C12H11ClO3 |
详情 |
详情
|
合成路线3
该中间体在本合成路线中的序号:
(VI) The protection of ethanolamine (I) with trityl chloride (II) in isopropanol gives N-tritylethanolamine (III), which is condensed with ethyl 4-chloroacetoacetate (IV) by means of NaH in THF to yield ethyl 4-[2-(tritylamino)ethoxy]acetoacetate (V). The cyclization of (V) with 2-chlorobenzaldehyde (VI) and methyl 3-aminocrotonate (VII) in refluxing methanol affords the protected dihydropyridine (VIII), which, without isolation, is finally detritylated by a treatment with aqueous benzenesulfonic acid.
【1】
Furlan, B.; Copar, A.; Jeriha, A. (LEK Pharmaceutical and Chemical Co.); 3-Ethyl 5-methyl (+)2-[2-(N-tritylamino)ethoxymethyl]-4-(2-chloro-phenyl)-1,4-dihydro-6-methyl-6-methyl-3, 5-pyridinedicarboxylate. EP 0599220; US 5389654 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10259 |
Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol |
141-43-5 |
C2H7NO |
详情 | 详情
|
(II) |
48259 |
1-(2-chloro-1,1-diphenylethyl)benzene
|
|
C20H17Cl |
详情 |
详情
|
(III) |
48260 |
2-(tritylamino)-1-ethanol
|
|
C21H21NO |
详情 |
详情
|
(IV) |
23541 |
ethyl 4-chloro-3-oxobutanoate;Ethyl 4-chloro-3-oxobutanoate;Ethyl 4-chloroacetoacetate |
638-07-3 |
C6H9ClO3 |
详情 | 详情
|
(V) |
48261 |
ethyl 3-oxo-4-[2-(tritylamino)ethoxy]butanoate
|
|
C27H29NO4 |
详情 |
详情
|
(VI) |
24114 |
2-chlorobenzaldehyde
|
89-98-5 |
C7H5ClO |
详情 | 详情
|
(VII) |
11372 |
Methyl (E)-3-amino-2-butenoate; Methyl 3-aminocrotonate
|
|
C5H9NO2 |
详情 |
详情
|
(VIII) |
48262 |
5-ethyl 3-methyl 4-(2-chlorophenyl)-2-methyl-6-[[2-(tritylamino)ethoxy]methyl]-1,4-dihydro-3,5-pyridinedicarboxylate
|
|
C39H39ClN2O5 |
详情 |
详情
|
合成路线4
该中间体在本合成路线中的序号:
(VII) The two enantiomers of amlodipine have been obtained as follows:
The reaction of 2-azidoethanol (I) with chloroacetic acid (II) by means of NaH in THF gives 2-(2-azidoethoxy)acetic acid (III), which is condensed with Meldrum's acid (IV) and 3-hydroxypropionitrile (V) in dichloromethane to yield the 2-cyanoethyl acetoacetate (VI). The cyclization of (VI) with 2-chlorobenzaldehyde (VII) and methyl 3-aminocrotonate (VIII) in refluxing ethanol affords the dihydropyridine (IX), which is selectively hydrolyzed at the 2-cyanoethylester with NaOH to give the dihydropyridine monocarboxylic acid (X). The esterification of (X) with (S)-2-methoxy-2-phenylethanol (XI) by means of CDI in dichloromethane provides the ester (XII) as a diastereomeric mixture, which is separated by chromatography to furnish diastereomers (XXI A) and (XII B). The selective ethanolysis of (XII A) and (XII B) with sodium ethoxide in refluxing ethanol/diglyme gives enantiomers (+)-(XIII) and (-)-(XIII), which are finally reduced with H2 over Pd/CaCO3 in ethanol to afford the (-)- and (+)-isomers, respectively, of the target compound.
【1】
Arrowsmith, J.E.; et al.; Long-acting dihydropyridine calcium antagonists. 1. 2-Alkoxymethyl derivatives incorporating basic substituents. J Med Chem 1986, 29, 9, 1696.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
24111 |
2-azido-1-ethanol
|
|
C2H5N3O |
详情 |
详情
|
(II) |
11847 |
2-Chloroacetic acid; Chloroacetic Acid
|
79-11-8 |
C2H3ClO2 |
详情 | 详情
|
(III) |
48263 |
2-(2-azidoethoxy)acetic acid
|
|
C4H7N3O3 |
详情 |
详情
|
(IV) |
14738 |
Meldrum's acid; 2,2-dimethyl-1,3-dioxane-4,6-dione;Malonic acid cyclic isopropylidene ester |
2033-24-1 |
C6H8O4 |
详情 | 详情
|
(V) |
14029 |
Ethylene cyanohydrin; ECN; 3-Hydroxypropanenitrile
|
109-78-4 |
C3H5NO |
详情 | 详情
|
(VI) |
48264 |
2-cyanoethyl 4-(2-azidoethoxy)-3-oxobutanoate
|
|
C9H12N4O4 |
详情 |
详情
|
(VII) |
24114 |
2-chlorobenzaldehyde
|
89-98-5 |
C7H5ClO |
详情 | 详情
|
(VIII) |
11372 |
Methyl (E)-3-amino-2-butenoate; Methyl 3-aminocrotonate
|
|
C5H9NO2 |
详情 |
详情
|
(IX) |
48265 |
3-(2-cyanoethyl) 5-methyl 2-[(2-azidoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydro-3,5-pyridinedicarboxylate
|
|
C21H22ClN5O5 |
详情 |
详情
|
(X) |
48266 |
2-[(2-azidoethoxy)methyl]-4-(2-chlorophenyl)-5-(methoxycarbonyl)-6-methyl-1,4-dihydro-3-pyridinecarboxylic acid
|
|
C18H19ClN4O5 |
详情 |
详情
|
(XI) |
48267 |
(2S)-2-methoxy-2-phenyl-1-ethanol
|
66051-01-2 |
C9H12O2 |
详情 | 详情
|
(XII) |
48268 |
3-[(2S)-2-methoxy-2-phenylethyl] 5-methyl 2-[(2-azidoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydro-3,5-pyridinedicarboxylate
|
|
C27H29ClN4O6 |
详情 |
详情
|
(XIII) |
24115 |
3-ethyl 5-methyl 2-[(2-azidoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydro-3,5-pyridinedicarboxylate
|
|
C20H23ClN4O5 |
详情 |
详情
|
合成路线5
该中间体在本合成路线中的序号:
(V) The reaction of ethyl 4-bromoacetoacetate (I) with 2-chloroethanol (II) by means of NaH in THF gives ethyl 4-(2-chloroethoxy)acetoacetate (III), which is treated with NaI in refluxing acetone to yield the corresponding 2-iodoethoxy derivative (IV). The condensation of (IV) with 2-chlorobenzaldehyde (V) by means of piperidine acetate in isopropanol affords ethyl 2-(2-chlorobenzylidene)-4-(2-iodoethoxy)acetoacetate (VI), which is cyclized with methyl 3-aminocrotonate (VII) in refluxing isopropanol to provide the dihydropyridine (VIII). The reaction of (VIII) with hexamethylenetetramine (IX) in hot acetonitrile gives the aminium salt (X), which is finally treated with benzenesulfonic acid in refluxing butanol (methanol)/water.
Alternatively, the intermediate dihydropyridine (VIII) can be obtained as follows: The condensation of ethyl 4-(2-chloroethoxy)acetoacetate (III) with the aldehyde (V) by means of piperidine acetate in isopropanol gives ethyl 2-(2-chlorobenzylidene)-4-(2-chloroethoxy)acetoacetate (XI), which is cyclized with methyl 3-aminocrotonate (VII) in refluxing isopropanol to yield the corresponding dihydropyridine (XII). Finally, this compound is treated with NaI in refluxing isopropanol to afford the target intermediate dihydropyridine (VIII).
【1】
Németh, N.; Vereczkey, G.D.; Krasznai, G.; Koványi, G.; Német, G.; Blask, G.; Tömpe, P.; Nagy, K.; Bozsing, D.; Simig, G. (Egis Pharmaceuticals Ltd.); A process and intermediate cpds. for the preparation of amlodipine benzene sulphonate. EP 0902016 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
36651 |
Ethyl (bromoacetyl)acetate;ethyl 4-bromo-3-oxobutanoate |
13176-46-0 |
C6H9BrO3 |
详情 | 详情
|
(II) |
10384 |
2-Chloro-1-ethanol; Ethylene chlorohydrin
|
107-07-3 |
C2H5ClO |
详情 | 详情
|
(III) |
48269 |
ethyl 4-(2-chloroethoxy)-3-oxobutanoate
|
|
C8H13ClO4 |
详情 |
详情
|
(IV) |
48270 |
ethyl 4-(2-iodoethoxy)-3-oxobutanoate
|
|
C8H13IO4 |
详情 |
详情
|
(V) |
24114 |
2-chlorobenzaldehyde
|
89-98-5 |
C7H5ClO |
详情 | 详情
|
(VI) |
48271 |
ethyl (Z)-3-(2-chlorophenyl)-2-[2-(2-iodoethoxy)acetyl]-2-propenoate
|
|
C15H16ClIO4 |
详情 |
详情
|
(VII) |
11372 |
Methyl (E)-3-amino-2-butenoate; Methyl 3-aminocrotonate
|
|
C5H9NO2 |
详情 |
详情
|
(VIII) |
48272 |
3-ethyl 5-methyl 4-(2-chlorophenyl)-2-[(2-iodoethoxy)methyl]-6-methyl-1,4-dihydro-3,5-pyridinedicarboxylate
|
|
C20H23ClINO5 |
详情 |
详情
|
(IX) |
34873 |
1,3,5,7-tetraazatricyclo[3.3.1.1(3,7)]decane
|
100-97-0 |
C6H12N4 |
详情 | 详情
|
(X) |
48273 |
1-(2-[[4-(2-chlorophenyl)-3-(ethoxycarbonyl)-5-(methoxycarbonyl)-6-methyl-1,4-dihydro-2-pyridinyl]methoxy]ethyl)-3,5,7-triaza-1-azoniatricyclo[3.3.1.1(3,7)]decane iodide
|
|
C26H35ClIN5O5 |
详情 |
详情
|
(XI) |
48274 |
ethyl (Z)-2-[2-(2-chloroethoxy)acetyl]-3-(2-chlorophenyl)-2-propenoate
|
|
C15H16Cl2O4 |
详情 |
详情
|
(XII) |
48275 |
3-ethyl 5-methyl 2-[(2-chloroethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydro-3,5-pyridinedicarboxylate
|
|
C20H23Cl2NO5 |
详情 |
详情
|
合成路线6
该中间体在本合成路线中的序号:
(IV) The reaction of 4,5-bis(hydroxymethyl)-2,2-dimethyl-1,3-dioxolane (I) with ethyl 4-chloroacetoacetate (II) gives the bis adduct (III), which is cyclized with 2-chlorobenzaldehyde (IV) and methyl 3-aminocrotonate (V) in refluxing ethanol to yield the dimeric dihydropyridine (VI). The cleavage of the dioxolane ring of (VI) by means of Ts-OH in methanol affords the vicinal diol (VII), which is cleaved by means of NaIO4 in methanol to provide the acetaldehyde derivative (VIII). The reaction of (VIII) with hydroxylamine and TEA in methanol affords the corresponding oxime (IX), which is finally reduced to the target compound with Pd(OH)2/carbon and ammonium formate in refluxing methanol. Alternatively, the reductive amination of acetaldehyde (VIII) with ammonium acetate and sodium cyanoborohydride in methanol yields also the target compound.
【1】
Karimian, K.; Leung-Toung, R.C.S.H.; Tam, T.F. (Apotex Inc.); 1,4-Dihydropyridines, N-substd. bicyclic 4-hydropyridines, and bicyclic N-substd. 4,5-dihydropyridines. US 5723618 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
48276 |
(4R-trans)-2,2-dimethyl-1,3-dioxolan-4,5-dimethanol; [5-(hydroxymethyl)-2,2-dimethyl-1,3-dioxolan-4-yl]methanol; (-)-2,3-o-Isopropylidene-D-threitol
|
73346-74-4 |
C7H14O4 |
详情 | 详情
|
(II) |
23541 |
ethyl 4-chloro-3-oxobutanoate;Ethyl 4-chloro-3-oxobutanoate;Ethyl 4-chloroacetoacetate |
638-07-3 |
C6H9ClO3 |
详情 | 详情
|
(III) |
48277 |
ethyl 4-([5-[(4-ethoxy-2,4-dioxobutoxy)methyl]-2,2-dimethyl-1,3-dioxolan-4-yl]methoxy)-3-oxobutanoate
|
|
C19H30O10 |
详情 |
详情
|
(IV) |
24114 |
2-chlorobenzaldehyde
|
89-98-5 |
C7H5ClO |
详情 | 详情
|
(V) |
11372 |
Methyl (E)-3-amino-2-butenoate; Methyl 3-aminocrotonate
|
|
C5H9NO2 |
详情 |
详情
|
(VI) |
48278 |
3-ethyl 5-methyl 4-(2-chlorophenyl)-2-([[5-([[4-(2-chlorophenyl)-3-(ethoxycarbonyl)-5-(methoxycarbonyl)-6-methyl-1,4-dihydro-2-pyridinyl]methoxy]methyl)-2,2-dimethyl-1,3-dioxolan-4-yl]methoxy]methyl)-6-methyl-1,4-dihydro-3,5-pyridinedicarboxylate
|
|
C43H50Cl2N2O12 |
详情 |
详情
|
(VII) |
48279 |
3-ethyl 5-methyl 4-(2-chlorophenyl)-2-[(4-[[4-(2-chlorophenyl)-3-(ethoxycarbonyl)-5-(methoxycarbonyl)-6-methyl-1,4-dihydro-2-pyridinyl]methoxy]-2,3-dihydroxybutoxy)methyl]-6-methyl-1,4-dihydro-3,5-pyridinedicarboxylate
|
|
C40H46Cl2N2O12 |
详情 |
详情
|
(VIII) |
48280 |
5-ethyl 3-methyl 4-(2-chlorophenyl)-2-methyl-6-[(2-oxoethoxy)methyl]-1,4-dihydro-3,5-pyridinedicarboxylate
|
|
C20H22ClNO6 |
详情 |
详情
|
(IX) |
48258 |
3-ethyl 5-methyl 4-(2-chlorophenyl)-2-[[2-(hydroxyimino)ethoxy]methyl]-6-methyl-1,4-dihydro-3,5-pyridinedicarboxylate
|
|
C20H23ClN2O6 |
详情 |
详情
|
合成路线7
该中间体在本合成路线中的序号:
(IV) The reaction of 2,2-dimethyl-1,3-dioxolane-4-methanol (X) with ethyl 4-chloroacetoacetate (II) gives the adduct (XI), which is cyclized with 2-chlorobenzaldehyde (IV) and methyl 3-aminocrotonate (V) in refluxing ethanol to yield the dihydropyridine (XII). The cleavage of the dioxolane ring of (XII) by means of Ts-OH in methanol affords the vicinal diol (XIII), which is cleaved by means of NaIO4 in methanol to provide the already reported acetaldehyde derivative (VIII).
【1】
Karimian, K.; Leung-Toung, R.C.S.H.; Tam, T.F. (Apotex Inc.); 1,4-Dihydropyridines, N-substd. bicyclic 4-hydropyridines, and bicyclic N-substd. 4,5-dihydropyridines. US 5723618 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(II) |
23541 |
ethyl 4-chloro-3-oxobutanoate;Ethyl 4-chloro-3-oxobutanoate;Ethyl 4-chloroacetoacetate |
638-07-3 |
C6H9ClO3 |
详情 | 详情
|
(IV) |
24114 |
2-chlorobenzaldehyde
|
89-98-5 |
C7H5ClO |
详情 | 详情
|
(V) |
11372 |
Methyl (E)-3-amino-2-butenoate; Methyl 3-aminocrotonate
|
|
C5H9NO2 |
详情 |
详情
|
(VIII) |
48280 |
5-ethyl 3-methyl 4-(2-chlorophenyl)-2-methyl-6-[(2-oxoethoxy)methyl]-1,4-dihydro-3,5-pyridinedicarboxylate
|
|
C20H22ClNO6 |
详情 |
详情
|
(IX) |
48258 |
3-ethyl 5-methyl 4-(2-chlorophenyl)-2-[[2-(hydroxyimino)ethoxy]methyl]-6-methyl-1,4-dihydro-3,5-pyridinedicarboxylate
|
|
C20H23ClN2O6 |
详情 |
详情
|
(X) |
16476 |
2,2-dimethyl-4-hydroxymethyl-1,3-dioxolane; (2,2-dimethyl-1,3-dioxolan-4-yl)methanol; 2,3-o-Isopropylideneglycerol
|
100-79-8 |
C6H12O3 |
详情 | 详情
|
(XI) |
48281 |
ethyl 4-[(2,2-dimethyl-1,3-dioxolan-4-yl)methoxy]-3-oxobutanoate
|
|
C12H20O6 |
详情 |
详情
|
(XII) |
48282 |
3-ethyl 5-methyl 4-(2-chlorophenyl)-2-[[(2,2-dimethyl-1,3-dioxolan-4-yl)methoxy]methyl]-6-methyl-1,4-dihydro-3,5-pyridinedicarboxylate
|
|
C24H30ClNO7 |
详情 |
详情
|
(XIII) |
48283 |
3-ethyl 5-methyl 4-(2-chlorophenyl)-2-[(2,3-dihydroxypropoxy)methyl]-6-methyl-1,4-dihydro-3,5-pyridinedicarboxylate
|
|
C21H26ClNO7 |
详情 |
详情
|
合成路线8
该中间体在本合成路线中的序号:
(II) The condensation of 4-(2-phthalimidoethoxy)acetoacetic acid ethyl ester (I) with 2-chlorobenzaldehyde (II) by means of piperidine in isopropanol gives 2-(2-chlorobenzylidene)-4-(2-phthalimidoethoxy)acetoacetic acid ethyl ester (III), which is cyclized with 3-aminocrotonic acid methyl ester (IV) in hot isopropanol to yield the phthalimido amlodipine (V). Finally, this compound is deprotected by means of aqueous methylamine to afford the target amlodipine.
【1】
Benneker, F.B.G.; Peters, T.H.A.; Slanina, P.; Bartl, J.; Process for making amlodipine, derivs. thereof, and precursors therefor. WO 0253535 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
44032 |
Ethyl 4-(2-phthalimidoethoxy)acetoacetate;ETHYL4-[2-(1,3-DIOXO-1,3-DIHYDRO-2H-ISOINDOL-2-YL)ETHOXYL]-3-OXOBUTANOATE;Ethyl-4(2-Phthalimido Ethoxy)Acetoacetate;ethyl 4-(2-(1,3-dioxoisoindolin-2-yl)ethoxy)-3-oxobutanoate; Ethyl 4-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethoxy]-3-oxobutanoate |
88150-75-8 |
C16H17NO6 |
详情 | 详情
|
(II) |
24114 |
2-chlorobenzaldehyde
|
89-98-5 |
C7H5ClO |
详情 | 详情
|
(III) |
54215 |
ethyl (Z)-3-(2-chlorophenyl)-2-{2-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethoxy]acetyl}-2-propenoate
|
n/a |
C23H20ClNO6 |
详情 | 详情
|
(IV) |
11372 |
Methyl (E)-3-amino-2-butenoate; Methyl 3-aminocrotonate
|
|
C5H9NO2 |
详情 |
详情
|
(V) |
44035 |
Phthalimido amlodipine; Phthaloyl Amlodipine; 3-Ethyl 5-methyl 4-(2-chlorophenyl)-2-[[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethoxy]methyl]-6-methyl-1,4-dihydro-3,5-pyridinedicarboxylate
|
103094-30-0 |
C28H27ClN2O7 |
详情 | 详情
|
合成路线9
该中间体在本合成路线中的序号:
(I) Condensation of 2-chlorobenzaldehyde (I) with methyl 3-methoxy-2(E)-butenoate (II) in the presence of a strong base in dimethyl sulfoxide/water affords, after acidification and reesterification by ethyl bromide/potassium carbonate ethyl 5-(2-chlorophenyl)-3-methyl-2(E),4(E)-pentadienoate (III). Osmium tetroxide catalyzed dihydroxylation of (III) in acetone/water with N-methylmorpholine-N-oxide (NMO) as cooxidant exclusively yields ethyl 5-(2-chlorophenyl)-4,5-threo-dihydroxy-3-methoxy-2(E)-pentenoate (IV), which in acidic medium spontaneously lactonizes to give the parent compound.
【1】
Chatterjee, S.S.; Klessing, K. (Willmar Schwabe GmbH); 5-Arylalkyl-4-alkoxy-2(5H)-furanone derivs., intermediates and process for their preparation as well as use as therapeutic agents. DE 3615157; EP 0247320; JP 1988022087; US 4855320 .
|
【2】
Noldner, M.; Chatterjee, S.S.; LOSIGAMONE < Prop INN >. Drugs Fut 1990, 15, 10, 995.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
24114 |
2-chlorobenzaldehyde
|
89-98-5 |
C7H5ClO |
详情 | 详情
|
(II) |
31187 |
methyl (E)-3-methoxy-2-butenoate
|
|
C6H10O3 |
详情 |
详情
|
(III) |
31188 |
ethyl (2E,4E)-5-(2-chlorophenyl)-3-methoxy-2,4-pentadienoate
|
|
C14H15ClO3 |
详情 |
详情
|
(IV) |
31189 |
ethyl (E)-5-(2-chlorophenyl)-4,5-dihydroxy-3-methoxy-2-pentenoate
|
|
C14H17ClO5 |
详情 |
详情
|
合成路线10
该中间体在本合成路线中的序号:
(VIII) The reaction of [benzene-U-13C]benzoic acid (I) with SOCl2 gives the corresponding acyl chloride (II), which is cyclized with the ethanolamine (III) to yield the oxazoline (IV).The chlorination of (IV) with sec-BuLi and hexachloroethane in toluene affords the 2-chlorophenyl derivative (V), which is methylated with MeI to provide the oxazolinium salt (VI). The reduction of (VI) with NaBH4 in ethanol yields the oxazolidine (VII), which is hydrolyzed with HCl to afford the labeled 2-chlorobenzaldehyde (VIII). The condensation of aldehyde (VIII) with the tetrahydrothienopyridine (IX) by means of acetone cyanohydrine in hot toluene affords the substituted acetonitrile (X), which is hydrolyzed to the substituted acetamide (XI) with HCl in methanol. Finally, this compound is treated with H2SO4 in refluxing methanol to afford the target labeled methyl ester as a racemic mixture.
【1】
Kashimura, S.; Kuwata, F.; Ishige, O.; Uyama, H.; Shono, T.; Yamaguchi, Y.; Formation of a novel acyl anion equivalent by the electroreduction of oxazolinium salts. Chem Lett 1987, 1511.
|
【2】
Burgos, A.; Simpson, I.; Herbert, J.M.; Ortho-metalation/chlorination of benzoic acid derivatives: Preparation of [benzene-U-C-13]-rac-clopidogrel ([benzene-U-C-13]-rac-SR25990C). J Label Compd Radiopharm 2000, 43, 9, 891.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
63476 |
methyl 2-(2-chlorophenyl)-2-[6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]acetate
|
|
C16H16ClNO2S |
详情 |
详情
|
|
63477 |
methyl 2-(2-chlorophenyl)-2-[6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]acetate
|
|
C16H16ClNO2S |
详情 |
详情
|
(I) |
10202 |
Benzoic acid
|
65-85-0 |
C7H6O2 |
详情 | 详情
|
(I) |
44623 |
|
|
C7H6O2 |
详情 |
详情
|
(II) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(II) |
45137 |
|
|
C7H5ClO |
详情 |
详情
|
(III) |
21513 |
2-amino-2-methyl-1-propanol;Karl Fischer;2-Amino-2-methyl-propan-1-ol;2-amino-2-methyl-1-propanol |
124-68-5 |
C4H11NO |
详情 | 详情
|
(IV) |
44072 |
4,4-dimethyl-2-phenyl-4,5-dihydro-1,3-oxazole
|
19312-06-2 |
C11H13NO |
详情 | 详情
|
(IV) |
45138 |
|
|
C11H13NO |
详情 |
详情
|
(V) |
44073 |
2-(2-chlorophenyl)-4,4-dimethyl-4,5-dihydro-1,3-oxazole
|
|
C11H12ClNO |
详情 |
详情
|
(V) |
45139 |
|
|
C11H12ClNO |
详情 |
详情
|
(VI) |
44074 |
2-(2-chlorophenyl)-3,4,4-trimethyl-4,5-dihydro-1,3-oxazol-3-ium iodide
|
|
C12H15ClINO |
详情 |
详情
|
(VI) |
45140 |
|
|
C12H15ClINO |
详情 |
详情
|
(VII) |
44075 |
2-(2-chlorophenyl)-3,4,4-trimethyl-1,3-oxazolidine
|
|
C12H16ClNO |
详情 |
详情
|
(VII) |
45141 |
|
|
C12H16ClNO |
详情 |
详情
|
(VIII) |
24114 |
2-chlorobenzaldehyde
|
89-98-5 |
C7H5ClO |
详情 | 详情
|
(VIII) |
45142 |
|
|
C7H5ClO |
详情 |
详情
|
(IX) |
34011 |
4,5,6,7-tetrahydrothieno[3,2-c]pyridine
|
54903-50-3 |
C7H9NS |
详情 | 详情
|
(X) |
44076 |
2-(2-chlorophenyl)-2-[6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]acetonitrile
|
|
C15H13ClN2S |
详情 |
详情
|
(X) |
45143 |
|
|
C15H13ClN2S |
详情 |
详情
|
(XI) |
44077 |
2-(2-chlorophenyl)-2-[6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]acetamide
|
|
C15H15ClN2OS |
详情 |
详情
|
(XI) |
45144 |
|
|
C15H15ClN2OS |
详情 |
详情
|
合成路线11
该中间体在本合成路线中的序号:
(II) The condensation of 4,5,6,7-tetrahydrothieno[3,2-c]pyridine (I) with 2-chlorobenzaldehyde (II) by means of either KCN/HCl, KCN/AcOH, NaHSO3/KCN, NaHSO3 /NaCN, NaHSO3/Tms-CN, NaCN/HCl or AcOH/cyclo[(S)-His-(S)-Phe] and HCN purge gives 2-(2-chlorophenyl)-2-(4,5,6,7-tetrahydrothieno[3,2-c]pyridin-5-yl)acetonitrile (III), which is hydrolyzed to the corresponding acetamide (IV) by means of either KOH, NaOH, NaOH followed by H2O2, refluxing HCl/TFA, formic acid/HCl, refluxing HBr, refluxing H2SO4 or refluxing HClO4. Finally, compound (III) is converted into the corresponding methyl ester with MeOH and either dimethylformamide dimethylacetal, H2SO4, Ms-OH, PPA, TiCl4, POCl3 or HCl.
【1】
Lohray, V.B.; Lohray, B.B.; Pandey, B. (Zydus-Cadila Group); Process for preparing clopidogrel. WO 02059128 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
63476 |
methyl 2-(2-chlorophenyl)-2-[6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]acetate
|
|
C16H16ClNO2S |
详情 |
详情
|
(I) |
34011 |
4,5,6,7-tetrahydrothieno[3,2-c]pyridine
|
54903-50-3 |
C7H9NS |
详情 | 详情
|
(II) |
24114 |
2-chlorobenzaldehyde
|
89-98-5 |
C7H5ClO |
详情 | 详情
|
(III) |
44076 |
2-(2-chlorophenyl)-2-[6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]acetonitrile
|
|
C15H13ClN2S |
详情 |
详情
|
(IV) |
44077 |
2-(2-chlorophenyl)-2-[6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]acetamide
|
|
C15H15ClN2OS |
详情 |
详情
|
合成路线12
该中间体在本合成路线中的序号:
(XIV) The synthesis of moxifetin was described according to the following methods:
1) The first synthesis starts from the acid (I), which is prepared either by reaction of 3-methoxythiophenol (V) with 2-iodobenzoic acid (IX) in boiling aqueous potassium hydroxide in the presence of copper, or by reaction of thiosalicylic acid (X) with 3-bromoanisole (XI) in boiling dimethylformamide in the presence of potassium carbonate and copper. The acid (I) is transformed to the acid chloride (II) by treatment with thionyl chloride in boiling benzene in the presence of a small quantity of dimethylformamide. Treatment of the benzene solution of (II) with dimethylamine (XII) under various conditions results in the amide (III), which is reduced to the amine (IV) either with lithium aluminum hydride in ether or with diborane, generated in situ by reaction of sodium borohydride with boron trifluoride etherate in tetrahydrofuran (this method proceeds via the corresponding amine borane which has to be hydrolyzed with sodium hydroxide in boiling aqueous ethanol). The reaction of (III) with phosphoryl chloride, followed by sodium borohydride in ethanol, also results in the amine (IV). This methoxy compound is demethylated in the final step to the desired compound (V) either by heating with pyridine hydrochloride to 210-220 C, by treatment with boron tribromide in chloroform or by refluxing with hydrobromic acid.
2) A shorter synthesis begins with the aldehyde (VI), obtained by reaction of 3-methoxythiophenol (XIII) with 2-chlorobenzaldehyde (XIV) in dimethylformamide at 90 C in the presence of potassium carbonate. Leuckart reaction of (VI) with dimethylformamide and formic acid at 180 C directly affords the methoxy amine (IV). Even a procedure via intermediates (VII) and (VIII), i.e., without protection of the phenolic hydroxyl, is feasible. Refluxing 3-hydroxythiophenol (XV) with 2-iodobenzoic acid (XVI) in aqueous potassium hydroxide in the presence of copper affords the hydroxy acid (VII) in a reasonable yield. The following reaction with dimethylamine (XII), leading to the hydroxy amide (VIII), proceeds in the presence of the complex of triphenylphosphine and tetrachloromethane. The final reduction of (VIII) to moxifetin (V) is carried out with lithium aluminum hydride in tetrahydrofuran. The moxifetin base is converted by reactions with acids to crystalline salts, viz. hydrobromide and hydrogen maleate.
【1】
Nemec, J.; Metysová, J.; Protiva, M.; Bártl, V.; Metys, J.; Neurotropic and psychotropic agents. LXIII. 7-Methoxy-10-(4-methylpiperazino)dibenzo[b,f]thiepin and its 10,11-dihydro derivative. Coll Czech Chem Commun 1973, 38, 2301-6. |
【2】
Schneider, B.; Hasek, J.; Jecny, J.; Crystal and molecular structure of 2-dimethylaminomethyl-3'-hydroxydiphenyl sulfide maleate. Coll Czech Chem Commun 1990, 55, 1529-34.
|
【3】
Jílek, J.; Valchár, M.; Protiva, M.; Metysová, J.; Sindelár, K.; A novel series of potential antidepressants and selective 5-HT uptake inhibitors. XIth Int Symp Med Chem (Sept 2-7, Jerusalem) 1990, 3. |
【4】
Pomykacek, J.; Sindelar, K.; Jilek, J.; et al.; Potential antidepressants: 2-(Methoxy- and hydroxy-phenylthio)-benzylamines as selective inhibitors of 5 hydroxytryptamine re-uptake in the brain. Coll Czech Chem Commun 1989, 54, 12, 3294-338.
|
【5】
Protiva, M.; Moxifetin Hydrogen Maleate. Drugs Fut 1991, 16, 10, 911.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
13625 |
2-[(3-Methoxyphenyl)sulfanyl]benzoic acid
|
|
C14H12O3S |
详情 |
详情
|
(II) |
13626 |
2-[(3-Methoxyphenyl)sulfanyl]benzoyl chloride
|
|
C14H11ClO2S |
详情 |
详情
|
(III) |
13627 |
2-[(3-Methoxyphenyl)sulfanyl]-N,N-dimethylbenzamide
|
|
C16H17NO2S |
详情 |
详情
|
(IV) |
13628 |
N-[2-[(3-Methoxyphenyl)sulfanyl]benzyl]-N,N-dimethylamine; [2-[(3-Methoxyphenyl)sulfanyl]phenyl]-N,N-dimethylmethanamine
|
|
C16H19NOS |
详情 |
详情
|
(V) |
25746 |
2-(benzyloxy)-5-chloro-3-[4-(methylsulfonyl)phenyl]pyridine; 4-[2-(benzyloxy)-5-chloro-3-pyridinyl]phenyl methyl sulfone
|
|
C19H16ClNO3S |
详情 |
详情
|
(VI) |
13630 |
2-[(3-Methoxyphenyl)sulfanyl]benzaldehyde
|
|
C14H12O2S |
详情 |
详情
|
(VII) |
13631 |
2-[(3-Hydroxyphenyl)sulfanyl]benzoic acid
|
|
C13H10O3S |
详情 |
详情
|
(VIII) |
13632 |
2-[(3-Hydroxyphenyl)sulfanyl]-N,N-dimethylbenzamide
|
|
C15H15NO2S |
详情 |
详情
|
(IX) |
37170 |
2-(10,11-dihydro-5H-dibenzo[b,f]azepin-3-yl)-2-(hydroxyimino)acetic acid
|
|
C16H14N2O3 |
详情 |
详情
|
(X) |
63792 |
2-sulfanylbenzoic acid; thiosalicylic acid |
147-93-3 |
C7H6O2S |
详情 | 详情
|
(XI) |
35983 |
m-bromoanisole; 1-Bromo-3-methoxybenzene; 3-Bromoanisole; 3-Bromophenyl methyl ether
|
2398-37-0 |
C7H7BrO |
详情 | 详情
|
(XII) |
19443 |
N-methylmethanamine; N,N-dimethylamine
|
124-40-3 |
C2H7N |
详情 | 详情
|
(XIII) |
25756 |
3-methoxybenzenethiol
|
15570-12-4 |
C7H8OS |
详情 | 详情
|
(XIV) |
24114 |
2-chlorobenzaldehyde
|
89-98-5 |
C7H5ClO |
详情 | 详情
|
(XV) |
63793 |
3-sulfanylphenol
|
|
C6H6OS |
详情 |
详情
|
(XVI) |
37160 |
2-iodobenzoic acid
|
88-67-5 |
C7H5IO2 |
详情 | 详情
|
合成路线13
该中间体在本合成路线中的序号:
(IV) Reaction of 2',5'-dihydroxyacetophenone (I) with dihydropyran (II) and pyridinium p-toluenesulfonate gives the protected bis-tetrahydropyranyl ether (III), which is submitted to Claisen-Schmidt condensation with 2-chlorobenzaldehyde (IV) in the presence of barium hydroxide, yielding the chalcone (V). Finally, the tetrahydropyranyl protecting groups of (V) are removed by acidic hydrolysis with p-toluenesulfonic acid in MeOH.
【1】
Nam, N.-H.; Kim, Y.; You, Y.-J.; Hong, D.-H.; Kim, H.-M.; Ahn, B.-Z.; Cytotoxic 2',5'-dihydroxychalcones with unexpected antiangiogenic activity. Eur J Med Chem 2003, 38, 2, 179.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
38479 |
1-(2,5-dihydroxyphenyl)-1-ethanone
|
490-78-8 |
C8H8O3 |
详情 | 详情
|
(II) |
13684 |
3,4-Dihydro-2H-pyran;2,3-Dihydro-4H-pyran; 5,6-Dihydro-4H-pyran;Dihydropyran |
110-87-2 |
C5H8O |
详情 | 详情
|
(III) |
64828 |
1-[2,5-bis(tetrahydro-2H-pyran-2-yloxy)phenyl]-1-ethanone
|
|
C18H24O5 |
详情 |
详情
|
(IV) |
24114 |
2-chlorobenzaldehyde
|
89-98-5 |
C7H5ClO |
详情 | 详情
|
(V) |
64829 |
(E)-1-[2,5-bis(tetrahydro-2H-pyran-2-yloxy)phenyl]-3-(2-chlorophenyl)-2-propen-1-one
|
|
C25H27ClO5 |
详情 |
详情
|
合成路线14
该中间体在本合成路线中的序号:
(VII)
【1】
Arrowsmith JE,Campbell SF,Cross PE,et al.Long-acting dihydropyridine calcium antagonists.1.2-Alkoxymethyl derivatives incorporating basic substituents.J Med Chem,1986,29:1696. |
【2】
Campbell SF,Cross PE,Stubbs JK.Dihydropyridine anti-ischemic and antihypertensive agents and pharmaceutical compositions containing them:EP,Patent 89,167,1983. |
【3】
Billman JH,Parker EE.Amino acids.I.Glycine.J Am Chem Soc,1943,65:761. |
【4】
Soine TO,Buchdahl MR.β-Bromoethylphalimide.Org Synth,1952,32:18. |
【5】
Peters THA,Benneker FBG,Slanina PBJ.Process for making amlodipine,derivatives thereof,and precursors thereof:US,Patent 2,002,143,046,2002. |
【6】
Alsan T,Adiyaman M,Yurdakul A,et al.Isolation of dihydropyridine derivative and preparation salts thereof:WO,Patent 2,004,058,711,2004. |
【7】
Bolugoddu V.Dahyabhai JL.Pingili RR.et al.Process for preparing amlodipine:US,Patent 2,007,260,065,2007. |
【8】
Purohit AK,Desai BC,Shete BD,et al.Process for the preparation of anti-ischemic and anti-hypertensive drug amlodipine besylate:US,Patent 2,004,044,218,2004. |
【9】
Davison E,Wells JI.Salts of amlodipine:DE,Patent 3,710,457,1987. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11900 |
2-Benzofuran-1,3-dione;1,2-Benzenedicarboxylic Anhydride;1,2-BENZENE DICARBOXYLIC ACID ANHYDRIDE;1,2-BENZENEDICARBONIC ACID, ANHYDRIDE;1,3-DIOXOPHTHALAN;1,3-ISOBENZOFURANDIONE;o-phthalic anhydride; Phthalic anhydride |
85-44-9 |
C8H4O3 |
详情 | 详情
|
(II) |
58854 |
2-(2-hydroxyethyl)-1H-isoindole-1,3(2H)-dione;N-Hydroxyethylphthalimide;N-(2-Hydroxyethyl)phthalimide;2-(2-hydroxyethyl)isoindoline-1,3-dione |
3891-07-4 |
C10H9NO3 |
详情 | 详情
|
(III) |
44032 |
Ethyl 4-(2-phthalimidoethoxy)acetoacetate;ETHYL4-[2-(1,3-DIOXO-1,3-DIHYDRO-2H-ISOINDOL-2-YL)ETHOXYL]-3-OXOBUTANOATE;Ethyl-4(2-Phthalimido Ethoxy)Acetoacetate;ethyl 4-(2-(1,3-dioxoisoindolin-2-yl)ethoxy)-3-oxobutanoate; Ethyl 4-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethoxy]-3-oxobutanoate |
88150-75-8 |
C16H17NO6 |
详情 | 详情
|
(IV) |
54215 |
ethyl (Z)-3-(2-chlorophenyl)-2-{2-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethoxy]acetyl}-2-propenoate
|
n/a |
C23H20ClNO6 |
详情 | 详情
|
(V) |
44035 |
Phthalimido amlodipine; Phthaloyl Amlodipine; 3-Ethyl 5-methyl 4-(2-chlorophenyl)-2-[[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethoxy]methyl]-6-methyl-1,4-dihydro-3,5-pyridinedicarboxylate
|
103094-30-0 |
C28H27ClN2O7 |
详情 | 详情
|
(VI) |
23541 |
ethyl 4-chloro-3-oxobutanoate;Ethyl 4-chloro-3-oxobutanoate;Ethyl 4-chloroacetoacetate |
638-07-3 |
C6H9ClO3 |
详情 | 详情
|
(VII) |
24114 |
2-chlorobenzaldehyde
|
89-98-5 |
C7H5ClO |
详情 | 详情
|
(VIII) |
10158 |
Piperidine
|
110-89-4 |
C5H11N |
详情 | 详情
|
(IX) |
69569 |
Methyl 3-aminocrotonate;Methyl 3-amino-2-butenoate;(Z)-methyl 3-aminobut-2-enoate |
14205-39-1 |
C5H9NO2 |
详情 | 详情
|
(X) |
69570 |
Benzenesulfonic acid;Phenylsulfonic acid;Benzenemonosulfonic acid;Benzensulfonic acid;Benzenesulphonic acid; |
98-11-3 |
C6H6O3S |
详情 | 详情
|
合成路线15
该中间体在本合成路线中的序号:
(II)
【1】
Arrowsmith JE,Campbell SF,Cross PE,et al.Long-acting dihydropyridine calcium antagonists.1.2-Alkoxymethyl derivatives incorporating basic substituents.J Med Chem,1986,29:1696. |
【2】
Campbell SF,Cross PE,Stubbs JK.Dihydropyridine anti-ischemic and antihypertensive agents and pharmaceutical compositions containing them:EP,Patent 89,167,1983. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11372 |
Methyl (E)-3-amino-2-butenoate; Methyl 3-aminocrotonate
|
|
C5H9NO2 |
详情 |
详情
|
(II) |
24114 |
2-chlorobenzaldehyde
|
89-98-5 |
C7H5ClO |
详情 | 详情
|
(III) |
24112 |
ethyl 4-(2-azidoethoxy)-3-oxobutanoate
|
|
C8H13N3O4 |
详情 |
详情
|
(IV) |
24115 |
3-ethyl 5-methyl 2-[(2-azidoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydro-3,5-pyridinedicarboxylate
|
|
C20H23ClN4O5 |
详情 |
详情
|
(V) |
69570 |
Benzenesulfonic acid;Phenylsulfonic acid;Benzenemonosulfonic acid;Benzensulfonic acid;Benzenesulphonic acid; |
98-11-3 |
C6H6O3S |
详情 | 详情
|
合成路线16
该中间体在本合成路线中的序号:
(II)
【1】
Arrowsmith JE,Campbell SF,Cross PE,et al.Long-acting dihydropyridine calcium antagonists.1.2-Alkoxymethyl derivatives incorporating basic substituents.J Med Chem,1986,29:1696. |
【2】
Campbell SF,Cross PE,Stubbs JK.Dihydropyridine anti-ischemic and antihypertensive agents and pharmaceutical compositions containing them:EP,Patent 89,167,1983. |
【3】
Chava S,Ramanjaneyulu GS,Rao KB.Process for the preparation of pure amlodipine:WO,Patent 2,006,003,672,2006. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11372 |
Methyl (E)-3-amino-2-butenoate; Methyl 3-aminocrotonate
|
|
C5H9NO2 |
详情 |
详情
|
(II) |
24114 |
2-chlorobenzaldehyde
|
89-98-5 |
C7H5ClO |
详情 | 详情
|
(III) |
44032 |
Ethyl 4-(2-phthalimidoethoxy)acetoacetate;ETHYL4-[2-(1,3-DIOXO-1,3-DIHYDRO-2H-ISOINDOL-2-YL)ETHOXYL]-3-OXOBUTANOATE;Ethyl-4(2-Phthalimido Ethoxy)Acetoacetate;ethyl 4-(2-(1,3-dioxoisoindolin-2-yl)ethoxy)-3-oxobutanoate; Ethyl 4-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethoxy]-3-oxobutanoate |
88150-75-8 |
C16H17NO6 |
详情 | 详情
|
(IV) |
44035 |
Phthalimido amlodipine; Phthaloyl Amlodipine; 3-Ethyl 5-methyl 4-(2-chlorophenyl)-2-[[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethoxy]methyl]-6-methyl-1,4-dihydro-3,5-pyridinedicarboxylate
|
103094-30-0 |
C28H27ClN2O7 |
详情 | 详情
|
(V) |
69570 |
Benzenesulfonic acid;Phenylsulfonic acid;Benzenemonosulfonic acid;Benzensulfonic acid;Benzenesulphonic acid; |
98-11-3 |
C6H6O3S |
详情 | 详情
|
合成路线17
该中间体在本合成路线中的序号:
(VI)
【1】
Moon YH,Kim ND,Lee KI,et al.Method for preparing amlodipine:US,Patent 2,002,132,834,2002. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10259 |
Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol |
141-43-5 |
C2H7NO |
详情 | 详情
|
(II) |
24848 |
acetonyl acetone;1,2-Diacetylethane;a,b-Diacetylethane;2,5-Diketohexane;Diacetonyl;Acetonylacetone;2,5-Dioxohexane;2,5-hexanedione |
110-13-4 |
C6H10O2 |
详情 | 详情
|
(III) |
69573 |
2-(2,5-Dimethylpyrrol-1-yl)ethanol;1H-Pyrrole-1-ethanol,2,5-dimethyl-;1-(2-Hydroxyethyl)-2,5-dimethylpyrrole;1-Hydroxyethyl-2,5-dimethylpyrrole |
83662-06-0 |
C8H13NO |
详情 | 详情
|
(IV) |
23541 |
ethyl 4-chloro-3-oxobutanoate;Ethyl 4-chloro-3-oxobutanoate;Ethyl 4-chloroacetoacetate |
638-07-3 |
C6H9ClO3 |
详情 | 详情
|
(V) |
69574 |
ethyl 4-(2-(2,5-dimethyl-1H-pyrrol-1-yl)ethoxy)-3-oxobutanoate |
|
C14H21NO4 |
详情 |
详情
|
(VI) |
24114 |
2-chlorobenzaldehyde
|
89-98-5 |
C7H5ClO |
详情 | 详情
|
(VII) |
69569 |
Methyl 3-aminocrotonate;Methyl 3-amino-2-butenoate;(Z)-methyl 3-aminobut-2-enoate |
14205-39-1 |
C5H9NO2 |
详情 | 详情
|
(VIII) |
69575 |
3-ethyl 5-methyl 4-(2-chlorophenyl)-2-((2-(2,5-dimethyl-1H-pyrrol-1-yl)ethoxy)methyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate |
|
C26H31ClN2O5 |
详情 |
详情
|
(IX) |
69570 |
Benzenesulfonic acid;Phenylsulfonic acid;Benzenemonosulfonic acid;Benzensulfonic acid;Benzenesulphonic acid; |
98-11-3 |
C6H6O3S |
详情 | 详情
|